HLA-G and cancer: Considering the impact of the immunoregulation induced by HLA-G expression and considering the role that different HLA-G subcomponents can have in the immune system of cancer patients, it can be assumed that the HLA-G detection in any of its forms may have clinical utility as a biomarker for the GC screening, in patients with gastric symptoms, to support the early diagnosis and follow up.